Expert clinical consultation bridging molecular diagnostics with actionable treatment guidance.
At AI Clinical Consulting, our mission is to empower healthcare providers with expert pathology interpretation for molecular diagnostic tests. We are dedicated to advancing antimicrobial stewardship, promoting effective therapies, and improving patient outcomes by bridging molecular diagnostics with clinical expertise.
We believe that every patient deserves access to expert clinical interpretation—not just raw laboratory data. Our board-certified pathologists review each case individually, translating complex PCR results and resistance gene markers into clear, actionable treatment recommendations.
By partnering with clinical laboratories, we help extend the reach of specialized pathology expertise to providers and patients who might otherwise lack access to this level of clinical consultation.
Every consultation reviewed by a board-certified pathologist
The principles that guide everything we do.
We maintain the highest standards of clinical accuracy, ensuring every recommendation is evidence-based and peer-reviewed.
We champion responsible antibiotic use, recommending the narrowest effective spectrum to combat antimicrobial resistance.
Every recommendation considers the individual patient, including comorbidities, allergies, and clinical context.
We complete reports efficiently, providing treatment considerations to providers in a timely manner. LIS integrations streamline workflow and enable quick turnaround times.
Each report is reviewed by a trained pathologist, detailing medications that provide antimicrobial coverage for specific detected pathogens, simplifying complex cases.
Treatment considerations for medication selection, dosages, and durations are based on clinical practice guidelines (IDSA, CDC, Sanford Guide) and current literature.
Our pathologists specialize in clinical interpretation of resistance gene data, using current literature to guide optimal antimicrobial selection.
Antimicrobial resistance occurs when bacteria become resistant to the drugs designed to eliminate them, posing a critical global health threat. Improving antibiotic use through antimicrobial stewardship is essential for patient safety.
Infections annually in the United States linked to antimicrobial resistance, leading to over 35,000 deaths.
Annual healthcare costs in the United States attributed to treatments related to antimicrobial resistance threats.
Efforts for prevention, infection control, and appropriate antimicrobial use have proven to reduce deaths from resistance.
Join leading laboratories in providing expert pathology consultation services that improve patient outcomes and add value to your clinical offerings.
Get Started Today